特布他林与糖皮质激素联合用于COPD治疗的疗效  

The Efficacy of Terbutaline and Glucocorticoids in the Treatment of COPD

作　　者：王腾 WANG Teng(Department of Respiratory Medicine,Yanzhou Branch of Affiliated Hospital of Jining Medical University,Jining Shandong 272100,China)

机构地区：[1]济宁医学院附属医院兖州院区呼吸内科,山东济宁272100

出　　处：《中国继续医学教育》2021年第10期154-156,共3页China Continuing Medical Education

摘　　要：目的对慢性阻塞性肺疾病患者采用特布他林联合糖皮质激素治疗的效果进行观察和比较。方法选择我院2018年2月-2019年2月收治的慢性阻塞性肺疾病患者80例纳入研究,按照硬币法予以随机分组处理,将这些患者划分为参照组(n=40)和试验组(n=40)。分别采用不同方式对参照组和试验组患者进行治疗,完成治疗后,比较两组患者的治疗效果。结果在总有效率方面,试验组为95.0%,参照组为77.5%,试验组明显高于参照组(P <0.05)。试验组与参照组在治疗前的血气指标比较没有统计学差异(P> 0.05),在治疗后,试验组的血气指标较之于参照组明显更好(P <0.05)。结论采用特布他林联合糖皮质激素治疗慢性阻塞性肺疾病患者具有很好的效果,值得临床应用。Objective To observe and compare the effects of terbutaline combined with glucocorticoid therapy in patients with COPD.Methods A total of 80 patients with chronic obstructive pulmonary disease from February 2018 to February 2019 in our hospital were selected for the study.They were randomly divided into groups according to the coin method,and these patients were divided into a reference group(n=40)and a test group(n=40).Different methods were used to treat patients in the reference group and the experimental group.After the treatment was completed,the treatment effects of the two groups were compared.Results In terms of total effective rate,the test group was 95.0%,the reference group was 77.5%,and the test group was significantly higher than the reference group(P<0.05).The blood gas indexes of the test group and the reference group before treatment were not significantly different(P>0.05).After treatment,the blood gas indexes of the test group were significantly better than those of the reference group(P<0.05).Conclusion The use of terbutaline combined with glucocorticoid in the treatment of patients with chronic obstructive pulmonary disease has a very good effect,and it is worthy of clinical application.

关 键 词：慢性阻塞性肺疾病 特布他林 糖皮质激素 丙酸氟替卡松气雾剂 疗效 血气指标 

分 类 号：R563[医药卫生—呼吸系统]